2026-07-28 · EN
FFH — Fairfax Financial Holdings Limited
Buy candidateFFH — Fairfax Financial Holdings Limited — deep-value analysis
Generated: 2026-07-28 · Primary listing: TSX (FFH, CAD) and TSX (FFH.U, USD); US OTC under FRFHF (pink sheet, illiquid). Financial reporting: USD, IFRS (IFRS 17 since 2023). SEC: foreign private issuer, CIK 915191, 40-F/6-K filer (NOT 10-K/20-F). Price used in the analysis: … USD (~CAD 2,390.56 at CADUSD rate 0.7069) — source: yfinance FFH.TO + FRFHF, 2026-07-28. Approx. market cap: ~… USD (~CAD 49.3bn).
Executive summary
Fairfax Financial Holdings is a P&C insurance and reinsurance holding company led by V. Prem Watsa (Chairman & CEO since 1985, 40 years of capital allocation), organized in a decentralized manner across dozens of underwriting subsidiaries (Allied World, Odyssey, Crum & Forster, Brit, Zenith, Northbridge, Gulf Insurance et al.) with investments managed centrally by Hamblin Watsa Investment Counsel. 2025 was “the best year in the company’s history” (CEO quote): net earnings … (…/diluted share), consolidated undiscounted combined ratio ** …**, record underwriting profit …, float … (…), book value per share … (…, or … dividend-adjusted).
Thesis: Fairfax is a demonstrated compounder — negative-cost float sustained for >35 years (historical average benefit … vs. the Canadian bond yield 3.1%), improving credit ratings (S&P BBB+→A-, A.M. Best bbb+→a-), disciplined buybacks (cumulative average price 2019-2025: …/share, less than half the current price) and optionality from Berkshire-style associate stakes (Eurobank, Poseidon, Digit). It doesn’t have a classic structural moat, however — it’s a cyclical business (underwriting) + an investment portfolio, and the discipline depends heavily on a single person.
Estimated value: the triangulated models give a very wide range — from a bear scenario where the stock should trade at a discount to book value (…), to a bull scenario that justifies nearly doubling the current price (…), with the base-case residual DCF at … but the statistical median of the 5 models at … (see the valuation section — the 5-year historical multiples suggest the stock has re-rated above its own average).
Verdict: INTERESTING (69.5%, GBL score 20.5/30) — a quality business with an excellent track record, but bought at a price that already reflects most of the good news of the last 2 years (P/B 1.34x vs. 5-year own average 1.04x; P/E 8.4x vs. average 6.1x). Not a “firm buy” position at the current price — it would become much more attractive on a pullback toward P/B ~1.1-1.2x.
Figures were removed from this excerpt. The full report opens free for five tickers a week — see what's open now.
Full report contents
- 🔒 Afacerea și moat-ul (Available in the full report)
- 🔒 Management și alocarea capitalului (Available in the full report)
- 🔒 Ce s-a schimbat în ultimele 4 trimestre (Q1 2025 → Q1 2026) (Available in the full report)
- 🔒 Red flags contabile (Available in the full report)
- 🔒 Evaluare triangulată (Available in the full report)
- 🔒 Pre-mortem — de ce teza ar putea fi greșită (Available in the full report)
- 🔒 Verdict comparat cu scorul GBL din tracker (Available in the full report)
Want the rest of this report?
Subscribe to get one full deep report a week by email, the day before it opens on the site.